NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Deciphex

Deciphex

Private
DublinHealthcare & Life Scienceshttps://www.deciphex.com/

Last Round

Debt

Oct 1, 2025

Total Funding Raised

$126.08M

Company Overview

Deciphex is a health technology company that develops artificial intelligence-powered digital pathology software and provides services to accelerate pathology diagnostics for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Drug Discovery, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pathologypathology AIcomputational pathologyhistopathologycontract research organizationCROmedical imagingAI diagnosticstissue analysisdrug discoverytelepathologypathology workflowSaaSclinical pathologyimage analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deciphex Comparables

Compare Deciphex with similar companies based on industry and business-model similarity.

Deciphex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AIRA Matrix
86%
Proscia
85%
Visiopharm
83%

Deciphex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 1, 2025
Series CJan 7, 2025
Series CJan 7, 2025
DebtOct 16, 2023
Series B ExtensionJan 25, 2023
Series B
May 19, 2022

Key People

Founding team and executive leadership

Andrea Rizzini

Chief Technology Officer

Executive Team

Mairin Rafferty

Chief Operations Officer (COO)

Executive Team

Ciara Mullin

Chief People Officer (CPO)

Executive Team

Deciphex Investors

Notable investors and investment history

Deciphex investors
InvestorRounds
ACT Venture CapitalSeries C, Series B Extension, Series A, Seed, Series B
Claret Capital PartnersDebt
Seroba Life SciencesSeries C, Series B Extension
GI PartnersSeries A, Seed
Inova Personalized Health AcceleratorSeed
NextSteps CapitalSeries C, Series B, Series B Extension, Series A, Seed
Department of Enterprise, Trade and EmploymentGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2023

    $11M round led by Claret Capital Partners

Deciphex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deciphex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deciphex's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin
Employee Range183
Year Founded2017
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.